Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and inflammatory joint diseases Monika MartiniakovaRoman BiroRadoslav Omelka Review Open access 16 February 2024 Pages: 435 - 452
Systemic and local effect of oxidative stress on recurrent aphthous stomatitis: systematic review Cristina EstornutGiulia RinaldiMartín Pérez-Leal Review 20 February 2024 Pages: 453 - 463
Emerging therapeutic targets in systemic sclerosis Steven O’Reilly Review 22 February 2024 Pages: 465 - 478
Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer Rafaela Nasser VeigaAlexandre Luiz Korte de AzevedoDaniela Fiori Gradia Review 23 February 2024 Pages: 479 - 493
The role of regulated necrosis in diabetes and its complications Haipeng PangGan HuangZhiguang Zhou Review 23 February 2024 Pages: 495 - 505
FDA-approved disulfiram as a novel treatment for aggressive leukemia Mawar KarsaLin XiaoKlaartje Somers Original Article Open access 13 February 2024 Pages: 507 - 519
Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage Nienke VisserLaure C. M. HerremanJon D. Laman Original Article Open access 21 February 2024 Pages: 521 - 536
The therapeutic effect of mesenchymal stem cells in diabetic kidney disease Umm E. HabibaNasar KhanAmna Umer Original Article Open access 29 February 2024 Pages: 537 - 570
The complement factor H-related protein-5 (CFHR5) exacerbates pathological bone formation in ankylosing spondylitis Ji-Hyun LeeSeung Hoon LeeChang-Nam Son Original Article 29 February 2024 Pages: 571 - 583